Announcement by Hanshang Group Co., Ltd. Regarding the Pledge of Part of the Company's Own Assets for a Loan and the Acceptance of a Guarantee from a Subsidiary

Stock Code: 600774
Stock Name: Han Shang Group
Announcement No.: 2026-007

Han Shang Group Co., Ltd.

Announcement on the Company Using Part of Its Own Assets for Mortgage Loans and Accepting Guarantees from Subsidiaries

The Company’s Board of Directors and all Directors guarantee that this announcement contains no false records, misleading statements, or major omissions, and they bear legal responsibility for the truthfulness, accuracy, and completeness of its content.

Han Shang Group Co., Ltd. (hereinafter referred to as “the Company”) was approved in March 2026 for a comprehensive credit line of 179 million yuan from Hankou Bank Co., Ltd., with a credit limit of 179 million yuan and a term of 12 months (hereinafter referred to as “this credit”). The Company will mortgage part of its own assets to Jianghan Branch of Hankou Bank Co., Ltd. (hereinafter “Hankou Bank” or “Party B”) to apply for working capital loans under this credit. Additionally, its wholly owned subsidiary, Chengdu Dikan Pharmaceutical Co., Ltd. (hereinafter “Dikan Pharmaceutical”), will provide joint liability guarantees for the working capital loans under this credit. The relevant matters are announced as follows:

1. The Company Mortgaging Part of Its Own Assets

2. Located at 3rd Floor, Building F, Renxin Han Shang Yinzuo, 139 Hanyang Avenue, Hanyang District, with a construction area of 5,833.87 square meters, property rights certificate No. 鄂（2021）Wuhan Hanyang No. 0027503; and 2nd Floor, Building F, same address, with a construction area of 5,815.22 square meters, property rights certificate No. 鄂（2021）Wuhan Hanyang No. 0027509. These two properties are the collateral for this mortgage.

On March 23, 2026, the Company signed the “Maximum Real Estate Mortgage Contract” (DB2026030400000013, DB2026030400000014) with Jianghan Branch of Hankou Bank, with a maximum financing period of 36 months, from March 23, 2026, to March 23, 2029. The mortgaged properties will serve as collateral for debts during this period.

2. The Company previously mortgaged properties to Hankou Bank Jianghan Branch: No. 577 Hanyang Avenue, Hanyang District, with a building area of 9,448.42 square meters, property rights certificate No. 鄂（2020）Wuhan Hanyang No. 0066860; No. 3, 1st-3rd floors, same address, with a building area of 13,940.4 square meters, property rights certificate No. 鄂（2020）Wuhan Hanyang No. 0050828; and No. 6 Victory Street, Jiang’an District, 1st Floor, with a building area of 6,275.27 square meters, property rights certificate No. 鄂（2021）Wuhan Jiang’an No. 0006308. These properties are also included in this year’s credit mortgage assets. On October 25, 2024, the Company signed the “Maximum Real Estate Mortgage Contract” (Nos. DB202409060000010, DB202409060000011, DB202409060000012) with Jianghan Branch of Hankou Bank, with a maximum financing period of 36 months, from October 25, 2024, to October 25, 2027.

This mortgage loan does not require approval from the Company’s Board of Directors or shareholders’ meeting as stipulated in the Articles of Association.

2. The Company Accepts Guarantees from Subsidiaries

3. Guarantee Overview

Dikan Pharmaceutical provides guarantee for the Company’s bank loans and other banking services from March 23, 2026, to March 23, 2027, with a maximum financing balance of 201.3 million yuan, and signed the “Maximum Guarantee Contract” (Contract No.: DB2026030400000012) with Party B on March 23, 2026.

2. Basic Information of the Guarantor

■■

Note: The above data are consolidated financial figures of Han Shang Group.

3. Main Terms of the Guarantee Agreement

(1) Guarantor: Chengdu Dikan Pharmaceutical Co., Ltd.
(2) Creditor: Jianghan Branch of Hankou Bank Co., Ltd.
(3) Guarantee Type: Joint liability guarantee
(4) Guarantee Amount: 201 million yuan
(5) Guarantee Period: Three years from the date of the guarantee, starting from the due date of each individual debt as stipulated in the contract. If the debt’s performance period is extended due to negotiations, the guarantee period will start from the new due date. If the debt is declared due early according to law or main contract, the guarantee period begins from the early due date.
(6) Additional Terms: The claims of Party B under the “Working Capital Loan Contracts” numbered HT2026010600000013 and HT2026010600000014, signed with the Company, are included within the scope of this maximum guarantee.

4. Necessity and Rationality of the Guarantee

The guarantee provided by Dikan Pharmaceutical, a wholly owned subsidiary, for the parent company does not occupy the Company’s approved external guarantee limit. The risk is within controllable range. This guarantee is to help the Company obtain bank credit smoothly and is in the interest of the Company and all shareholders.

5. Board of Directors’ Opinion

The above guarantee acceptance has been approved through Dikan Pharmaceutical’s internal procedures and does not require submission to the Company’s Board of Directors or shareholders’ meeting.

6. Total External Guarantees and Overdue Guarantees

As of the date of this announcement, the total external guarantees of the Company and its controlling subsidiaries amount to 294.3968 million yuan (excluding guarantees from subsidiaries to parent companies), representing 17.73% of the latest audited net assets. The total guarantees provided by the listed company to controlling subsidiaries amount to 214.5 million yuan, accounting for 12.92% of the latest audited net assets. The Company has no guarantees to controlling shareholders, actual controllers, or their related parties, nor any overdue guarantees.

The Company will determine the actual financing amount under the credit line reasonably based on operational needs, not exceeding the approved credit limit.

This announcement is hereby issued.

Han Shang Group Co., Ltd.
Board of Directors
March 24, 2026